Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis | All the latest summaries on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis

Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis
Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis

To investigate the prevalence of underdiagnosis and undertreatment of traditional cardiovascular risk factors in RA patients.


See All

Key take away

The treatment of the cardiovascular risk factors hypertension and hypercholesterolaemia in rheumatoid arthritis is of great concern. This is purely a review study based on special guidelines and evaluation tables to extrapolate the favorable results.

Background

To investigate the prevalence of underdiagnosis and undertreatment of traditional cardiovascular risk factors in RA patients.


Method

RA patients <=70 years of age without cardiovascular disease (CVD) or diabetes mellitus were included. Systolic blood pressure and a fasting lipid profile were measured. The 10-year CVD risk was estimated using the Dutch Cardiovascular Risk Management (CVRM) guideline and EULAR modifications of the Systemic Coronary Risk Evaluation tables.

Result

A total of 327 patients were included (female gender: 68%). The mean age was 53 (11) years [mean (S.D.)]. The median disease duration was 7 years (inter quartile range: 2–14 years). According to the CVRM guideline, 52% of the patients had a CVD risk ⩾20% and according to the EULAR guidelines, 18% of the patients had a CVD risk ≥ 20%. Low-density lipoprotein cholesterol (LDL-C) >2.5 mmol/l was found in >80% of the patients with a CVD risk ⩾10% as estimated by both the CVRM and EULAR guidelines, and 32–42% of the patients with a CVD risk ⩾10% had a systolic blood pressure >140 mmHg, depending on the risk model used. Statins were used in 6% and antihypertensives in 23–25%, and 50–86% of these patients did not reach the recommended treatment targets.

Conclusion

Regardless of the adapted risk assessment model used, untreated hypertension and hypercholesterolaemia were frequently found in RA patients with increased CVD risk. Treatment of these cardiovascular risk factors deserves more attention in RA.

Source:

Rheumatology (Oxford) 2016 Mar 23

Article:

Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis

Authors:

Deborah F. van Breukelen-van der Stoep et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: